By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

FSD Pharma Inc, through its wholly-owned subsidiary, is focused on Pharmaceutical research and development of its lead compound, FSD 201, ultra-micronized Palmitoyl ethylamine. The FSD 201 is known to stabilize mast cells of the human body and down-regulate the proinflammatory cytokines to effectuate an anti-inflammatory response.

Contact Information

Website: www.fsdpharma.com
Main Phone: +1 647 864-7969
Address: 100 King Street West
Address 2: Suite 3400
State: ON
City / Town: Toronto
Country: CA
Postal Code: M5X 1A4

Issuer Information

Exchange: NSC
CEO: Ron Downey
Employees: 9
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A